文献速递妇科

子宫混合性透明细胞/子宫内膜样和透明细胞/浆液性癌在临床病理上与纯透明细胞癌相似:一项NRG肿瘤学/妇科肿瘤组(GOG-210)对311名女性的研究

Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women.
PubMed 文献 · Gynecol Oncol · 2023-08-25

该研究基于GOG-210队列中311例子宫内膜癌患者,比较纯透明细胞癌、混合性及不确定性透明细胞癌的临床病理特征与生存。混合性透明细胞/子宫内膜样或透明细胞/浆液性癌的生存与纯透明细胞癌相似,而不确定性透明细胞/子宫内膜样组生存更长。

要点

  • 混合性透明细胞/子宫内膜样或透明细胞/浆液性癌的生存与纯透明细胞癌相似。
  • 不确定性透明细胞/子宫内膜样组的总生存更长。
  • 部分不确定性透明细胞肿瘤可能是模拟透明细胞癌的子宫内膜样癌。

核心结论

  • 在透明细胞子宫内膜癌中,存在明确的混合子宫内膜样或浆液性成分与预后无显著差异。
  • 肿瘤具有不确定性透明细胞特征的患者预后更好。
  • 这些肿瘤中有些可能是模拟透明细胞癌的子宫内膜样肿瘤。

研究设计与样本

  • GOG-210研究中的GOG-8032方案,纳入311例因子宫内膜癌行子宫切除术的患者,由专家病理学家中心复核组织学切片,分析基线和随访数据。
  • 混合性指具有多个可识别成分的肿瘤,不确定性指特征介于不同组织学类型之间的肿瘤。

主要发现

  • 136例为纯透明细胞癌,175例为混合性或不确定性透明细胞模式。
  • 除就诊年龄有微小差异外,基线临床病理特征相似。
  • 单因素生存分析证实典型子宫内膜癌预后因素的显著性。
  • 混合性类别患者的无病生存和总生存与纯透明细胞癌相似,但不确定性透明细胞/子宫内膜样组生存更长。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Clear cell carcinoma is a high-risk subtype of endometrial cancer. Some patients have a mixture of clear cell carcinoma with other histologic types (endometrioid or serous) or cannot be neatly assigned to one of these types. Protocol GOG-8032 within GOG-210 was designed to determine whether these tumors differ from pure clear cell carcinoma in stage at diagnosis, initial pattern of spread, or patient survival. METHODS: The term "mixed" was applied to tumors with multiple identifiable components, and "indeterminate" was applied to tumors with features intermediate between different histologic types. Three hundred eleven women with pure, mixed, or indeterminate clear cell carcinoma were identified in a larger cohort of patients undergoing hysterectomy for endometrial cancer in GOG-210. Histologic slides were centrally reviewed by expert pathologists. Baseline and follow-up data were analyzed. RESULTS: One hundred thirty-six patients had pure clear cell carcinoma and 175 had a mixed or indeterminate clear cell pattern. Baseline clinicopathologic characteristics were similar except for a small difference in age at presentation. Univariate survival analysis confirmed the significance of typical endometrial cancer prognostic factors. Patients in the mixed categories had disease-free and overall survival similar to pure clear cell carcinoma, but the indeterminate clear cell/endometrioid group had longer survival. CONCLUSION: In clear cell endometrial cancer, the presence of a definite admixed endometrioid or serous component did not correlate with a significant difference in prognosis. Patients whose tumors had indeterminate clear cell features had better prognosis. Some of these tumors may be endometrioid tumors mimicking clear cell carcinoma.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Hagemann IS, Deng W, Zaino RJ, et al. Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women. Gynecol Oncol. 2023. PMID: 37634258. doi:10.1016/j.ygyno.2023.08.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。